Neurohumoral Transmission in CNS: GABA, Glutamate & More
Neurohumoral Transmission in the CNS: Role of Key Neurotransmitters (GABA, Glutamate, Glycine, Serotonin, Dopamine)
Neurohumoral transmission in the CNS is one of the most high-yield topics for GPAT, university pharmacology exams, and allied health entrance tests. Understanding how chemical messengers like GABA, glutamate, glycine, serotonin, and dopamine work at the synapse is the foundation of modern neuropharmacology — and the key to understanding how most CNS drugs work.
In this blog, we break down the entire concept from basics to clinical application — with mnemonics, comparison tables, Canva diagram placeholders, and exam pearls. Let's get started! π§
π Table of Contents
- What is Neurohumoral Transmission?
- Steps of Chemical Synaptic Transmission in CNS
- Major Neurotransmitters in the CNS
- Glutamate – The Primary Excitatory Neurotransmitter
- GABA – The Main Inhibitory Neurotransmitter
- Glycine – Inhibitory Control in the Spinal Cord
- Serotonin – Mood and Homeostatic Regulator
- Dopamine – Reward, Movement, and Motivation
- Excitatory vs Inhibitory Balance and Disorders
- π Pharmacy/Clinical Angle (Why This Matters)
- π GPAT / Exam Pearls
- π§ Quick Revision Box
- ❓ Frequently Asked Exam Questions
- π£ Call to Action
What is Neurohumoral Transmission?
Neurohumoral transmission refers to the process by which neurons communicate with each other — or with effector cells — through the release of chemical messengers called neurotransmitters into the synaptic cleft.
In the central nervous system (CNS), this process governs everything from muscle movement and mood to memory, sleep, and pain perception. Unlike the peripheral nervous system (which uses acetylcholine and norepinephrine predominantly), the CNS relies on a diverse array of neurotransmitters — most importantly glutamate, GABA, glycine, serotonin, and dopamine.
Key Definition (Exam-Ready):
Neurohumoral transmission = Chemical communication between neurons via neurotransmitters released at the synapse → binds postsynaptic receptors → produces excitatory or inhibitory response.
 |
| Overview of neurohumoral transmission in the central nervous system, highlighting GABA, glutamate, glycine, serotonin, and dopamine with receptor binding and reuptake |
Steps of Chemical Synaptic Transmission in CNS
Understanding the steps of neurohumoral transmission is essential for GPAT and university exams. Here is the step-by-step process:
- Action potential arrives at the presynaptic terminal.
- Voltage-gated Ca²⁺ channels open → Ca²⁺ influx into the presynaptic neuron.
- Synaptic vesicles fuse with the presynaptic membrane (exocytosis).
- Neurotransmitter is released into the synaptic cleft.
- Neurotransmitter diffuses across the cleft and binds to postsynaptic receptors.
- Receptor activation causes EPSP (excitatory) or IPSP (inhibitory) in the postsynaptic neuron.
- Neurotransmitter is removed by: reuptake, enzymatic degradation, or diffusion.
π§ Mnemonic for Steps:
"Action potential Causes Vesicles to Release Neurotransmitters Binding Receptors"
→ A-C-V-R-N-B-R = "A Cat Very Rarely Needs Big Rooms"
Stepwise mechanism of chemical synaptic transmission in the CNS from action potential arrival to neurotransmitter removal
Major Neurotransmitters in the CNS
The CNS uses a wide variety of neurotransmitters. For exam purposes, focus on these five key players:
| Neurotransmitter | Type | Primary Location | Main Receptor(s) | Key Function |
|---|---|---|---|---|
| Glutamate | Excitatory | Widespread CNS | NMDA, AMPA, Kainate | Learning, memory, synaptic plasticity |
| GABA | Inhibitory | Widespread CNS | GABA-A, GABA-B | Reduces neuronal excitability, anti-anxiety |
| Glycine | Inhibitory | Spinal cord, brainstem | Glycine receptor (GlyR) | Motor control, reflex inhibition |
| Serotonin (5-HT) | Modulatory | Raphe nuclei → whole CNS | 5-HT1 to 5-HT7 | Mood, sleep, appetite, cognition |
| Dopamine | Modulatory | Substantia nigra, VTA | D1–D5 receptors | Reward, movement, motivation |
π§ Mnemonic to Remember All Five:
"Good Girls Don't Stay Dull"
→ Glutamate | Glycine | Dopamine | Serotonin | Dopamine... wait — try:
"Glutamate Gets Going; GABA Slows; Glycine Stops; Serotonin Soothes; Dopamine Drives"
Glutamate – The Primary Excitatory Neurotransmitter
Glutamate is the most abundant excitatory neurotransmitter in the CNS. It is involved in virtually every major brain function — from learning and memory to sensory processing and motor coordination.
Key Facts About Glutamate
- Synthesized from glutamine via glutaminase enzyme.
- Acts on ionotropic receptors: NMDA, AMPA, Kainate.
- Acts on metabotropic receptors: mGluR1–mGluR8.
- NMDA receptors require both glutamate binding AND membrane depolarization (Mg²⁺ block removal) to open — this is the basis of coincidence detection in memory formation (LTP).
- Excess glutamate → excitotoxicity → neuronal death (seen in stroke, epilepsy, ALS).
π§ Mnemonic:
"Glutamate = Go! (Excitatory) — Too much Go = Crash (Excitotoxicity)"
Glutamate acts as the main excitatory neurotransmitter in the CNS and excess activation can lead to excitotoxic neuronal damage
| Glutamate Receptors – Quick Comparison | |
|---|---|
| Receptor | Key Feature |
| NMDA | Voltage + ligand gated; Ca²⁺ permeable; Mg²⁺ block; role in LTP/memory |
| AMPA | Fast excitatory transmission; Na⁺/K⁺ permeable; mediates most fast EPSPs |
| Kainate | Presynaptic + postsynaptic; role in epilepsy |
| mGluR (metabotropic) | G-protein coupled; modulate synaptic transmission; slower effects |
GABA – The Main Inhibitory Neurotransmitter
GABA (Gamma-Aminobutyric Acid) is the principal inhibitory neurotransmitter in the CNS. It acts as the brain's natural "brake system," reducing neuronal excitability and maintaining the excitatory-inhibitory balance.
Key Facts About GABA
- Synthesized from glutamate via glutamate decarboxylase (GAD) — requires Vitamin B6 (pyridoxal phosphate) as cofactor.
- GABA-A receptor: Ionotropic; Cl⁻ channel; fast inhibition. Site of action for benzodiazepines, barbiturates, alcohol, general anaesthetics.
- GABA-B receptor: Metabotropic (GPCR); K⁺ channel opening / Ca²⁺ channel inhibition; slow inhibition. Site of action for baclofen.
- GABA deficiency → anxiety, seizures, insomnia.
π§ Mnemonic:
"GABA = Brakes on the Brain"
GABA-A = Anion (Cl⁻) channel = Anxiety relief
GABA-B = Baclofen's target = Backpain/spasticity
GABA-A receptor complex showing inhibitory chloride influx and key pharmacological binding sites targeted by CNS drugs
| GABA-A vs GABA-B Receptors | ||
|---|---|---|
| Feature | GABA-A | GABA-B |
| Type | Ionotropic (ligand-gated ion channel) | Metabotropic (GPCR) |
| Ion | Cl⁻ influx → hyperpolarization | K⁺ efflux / ↓Ca²⁺ influx |
| Speed | Fast (milliseconds) | Slow (seconds) |
| Drug targets | Benzodiazepines, Barbiturates, Alcohol, Propofol | Baclofen (muscle relaxant) |
| Clinical use | Anxiety, epilepsy, anaesthesia, insomnia | Spasticity, GERD, alcohol withdrawal |
Glycine – Inhibitory Control in the Spinal Cord
Glycine is the simplest amino acid and serves as a major inhibitory neurotransmitter in the spinal cord and brainstem. It is often overshadowed by GABA in exam prep, but it is equally important — especially for understanding strychnine poisoning and motor reflex control.
Key Facts About Glycine
- Acts on glycine receptors (GlyR) — ligand-gated Cl⁻ channels (similar to GABA-A).
- Mediates reciprocal inhibition in spinal cord motor circuits (e.g., when flexors contract, extensors are inhibited).
- Strychnine is a competitive antagonist at glycine receptors → causes convulsions and muscle rigidity (classic exam question!).
- Glycine also acts as a co-agonist at NMDA receptors (glutamate receptors) — required for NMDA receptor activation.
- Deficiency → hyperekplexia (startle disease).
π§ Mnemonic:
"Glycine = Guard of the Spinal Cord"
"Strychnine Stops Glycine → Spasms and Seizures"
(S-S-G-S-S = Strychnine Stops Glycine → Spasms + Seizures)
π Dual Role of Glycine (High-Yield!):
1. Inhibitory at GlyR (Cl⁻ channel) in spinal cord/brainstem
2. Co-agonist/Excitatory at NMDA receptors (glutamate system) in the brain
Serotonin – Mood and Homeostatic Regulator
Serotonin (5-Hydroxytryptamine / 5-HT) is a monoamine neurotransmitter synthesized primarily in the Raphe nuclei of the brainstem. It projects widely throughout the CNS and regulates a remarkable range of functions.
Key Facts About Serotonin
- Synthesized from tryptophan → 5-HTP → 5-HT (via tryptophan hydroxylase + AADC).
- Degraded by MAO-A → 5-HIAA (measured in urine as a marker).
- Receptors: 5-HT1 to 5-HT7 — mostly metabotropic (GPCR), except 5-HT3 (ionotropic, Na⁺/K⁺ channel).
- Functions: mood regulation, sleep-wake cycle, appetite, thermoregulation, nausea/vomiting, cognition.
- Low serotonin → depression, anxiety, OCD, insomnia.
- Excess serotonin → Serotonin Syndrome (hyperthermia, agitation, clonus — medical emergency).
π§ Mnemonic:
"Serotonin = SMASH"
Sleep | Mood | Appetite | Sexual function | Homeostasis
Serotonin pathway in the CNS showing its synthesis, raphe nuclei origin, and role in mood, sleep, appetite, and homeostasis
Dopamine – Reward, Movement, and Motivation
Dopamine is a catecholamine neurotransmitter and one of the most clinically significant molecules in neuropharmacology. It is central to understanding Parkinson's disease, schizophrenia, addiction, ADHD, and the mechanism of action of dozens of drugs.
Key Facts About Dopamine
- Synthesized from tyrosine → DOPA → Dopamine (via tyrosine hydroxylase + AADC).
- Degraded by MAO-B and COMT.
- Receptors: D1–D5 (all metabotropic/GPCR). D1/D5 = Gs (↑cAMP); D2/D3/D4 = Gi (↓cAMP).
The Four Major Dopamine Pathways
| Pathway | Origin → Destination | Function | Clinical Relevance |
|---|---|---|---|
| Nigrostriatal | Substantia nigra → Striatum | Motor control, movement | Degeneration → Parkinson's disease |
| Mesolimbic | VTA → Nucleus accumbens | Reward, pleasure, motivation | Overactivity → Schizophrenia (positive symptoms); Addiction |
| Mesocortical | VTA → Prefrontal cortex | Cognition, working memory, executive function | Underactivity → Schizophrenia (negative symptoms); ADHD |
| Tuberoinfundibular | Hypothalamus → Pituitary | Inhibits prolactin secretion | Blockade → Hyperprolactinemia (antipsychotic side effect) |
π§ Mnemonic for 4 Dopamine Pathways:
"Nice Men Make Trouble"
Nigrostriatal | Mesolimbic | Mesocortical | Tuberoinfundibular
Major dopamine pathways in the CNS with their roles in movement, reward, motivation, cognition, and prolactin regulation
Excitatory vs Inhibitory Balance and Disorders
The brain maintains a delicate balance between excitation (glutamate) and inhibition (GABA/glycine). When this balance is disrupted, neurological and psychiatric disorders emerge.
| Imbalance | Neurotransmitter Change | Resulting Disorder | Drug Strategy |
|---|---|---|---|
| ↑ Glutamate (excitotoxicity) | Excess NMDA activation → Ca²⁺ overload | Stroke, epilepsy, ALS, Alzheimer's | NMDA antagonists (Memantine, Ketamine) |
| ↓ GABA | Reduced inhibition | Epilepsy, anxiety, insomnia | Benzodiazepines, Barbiturates, Valproate |
| ↓ Glycine | Loss of spinal inhibition | Hyperekplexia, strychnine poisoning | Supportive; avoid strychnine |
| ↓ Serotonin | Reduced 5-HT signaling | Depression, OCD, anxiety, insomnia | SSRIs, SNRIs, MAOIs, TCAs |
| ↓ Dopamine (nigrostriatal) | Loss of motor control | Parkinson's disease | Levodopa + Carbidopa, Dopamine agonists |
| ↑ Dopamine (mesolimbic) | Excess D2 activation | Schizophrenia (positive symptoms) | Antipsychotics (D2 blockers) |
Comparison diagram of excitatory versus inhibitory neurotransmitters in the CNS, showing glutamate, GABA, and glycine balance in brain function
π Pharmacy/Clinical Angle (Why This Matters)
Understanding neurohumoral transmission in the CNS is not just academic — it directly explains the mechanism of action of the most commonly prescribed CNS drugs.
Key Drug Classes and Their Neurotransmitter Targets
| Drug Class | Target Neurotransmitter/Receptor | Mechanism | Clinical Use |
|---|---|---|---|
| Benzodiazepines (Diazepam) | GABA-A receptor | Positive allosteric modulator → ↑ Cl⁻ influx frequency | Anxiety, epilepsy, muscle relaxation, sedation |
| Barbiturates (Phenobarbitone) | GABA-A receptor | Positive allosteric modulator → ↑ Cl⁻ influx duration | Epilepsy, anaesthesia induction |
| SSRIs (Fluoxetine) | Serotonin (5-HT) reuptake transporter | Block SERT → ↑ synaptic 5-HT | Depression, OCD, panic disorder, PTSD |
| Levodopa + Carbidopa | Dopamine (nigrostriatal pathway) | Dopamine precursor; Carbidopa prevents peripheral conversion | Parkinson's disease |
| Antipsychotics (Haloperidol, Clozapine) | Dopamine D2 receptor | D2 receptor blockade → ↓ mesolimbic dopamine activity | Schizophrenia, bipolar disorder |
| Memantine | NMDA receptor (Glutamate) | Non-competitive NMDA antagonist → ↓ excitotoxicity | Alzheimer's disease (moderate-severe) |
| Baclofen | GABA-B receptor | GABA-B agonist → ↑ K⁺ efflux → hyperpolarization | Spasticity, muscle relaxation |
| Valproate | GABA (multiple mechanisms) | ↑ GABA synthesis + ↓ GABA degradation + Na⁺ channel block | Epilepsy, bipolar disorder, migraine prophylaxis |
π Exam Pearl 1:
Benzodiazepines INCREASE the FREQUENCY of Cl⁻ channel opening.
Barbiturates INCREASE the DURATION of Cl⁻ channel opening.
Mnemonic: "Benzo = Frequency; Barbi = Duration" → B-F, B-D
π Exam Pearl 2:
Strychnine poisoning = Glycine receptor antagonism → Treat with diazepam (GABA-A agonist) to compensate for lost inhibition. This is a classic GPAT question!
π GPAT / Exam Pearls
- π Glutamate = Most abundant excitatory NT in CNS; NMDA receptor requires both glutamate AND glycine as co-agonist.
- π GABA = Most abundant inhibitory NT in CNS; synthesized from glutamate via GAD (needs Vit B6).
- π Glycine = Main inhibitory NT in spinal cord; strychnine is its competitive antagonist.
- π Serotonin = Only 5-HT3 is ionotropic (Na⁺/K⁺); all others are metabotropic (GPCR).
- π Dopamine = D1/D5 → Gs → ↑cAMP; D2/D3/D4 → Gi → ↓cAMP.
- π Benzodiazepines = Frequency of Cl⁻ opening ↑; Barbiturates = Duration of Cl⁻ opening ↑.
- π Excitotoxicity = Excess glutamate → excess Ca²⁺ via NMDA → neuronal death.
- π Serotonin Syndrome = Excess 5-HT → hyperthermia + agitation + clonus (triad).
- π Parkinson's = ↓ dopamine in nigrostriatal pathway; Schizophrenia = ↑ dopamine in mesolimbic pathway.
- π Glycine dual role: Inhibitory at GlyR (spinal cord) + Co-agonist at NMDA receptor (brain).
π§ Quick Revision Box
⚡ 60-Second Revision: Neurohumoral Transmission in CNS
✅ Neurohumoral transmission = chemical communication via neurotransmitters at synapses
✅ Steps: AP → Ca²⁺ influx → vesicle fusion → NT release → receptor binding → EPSP/IPSP → NT removal
✅ Glutamate = Excitatory | GABA + Glycine = Inhibitory | Serotonin + Dopamine = Modulatory
✅ GABA-A = Cl⁻ channel (BZD/Barb target) | GABA-B = GPCR (Baclofen target)
✅ Glycine = Spinal cord inhibition; Strychnine = Glycine antagonist
✅ Serotonin = SMASH (Sleep, Mood, Appetite, Sexual function, Homeostasis)
✅ Dopamine pathways = Nice Men Make Trouble (Nigrostriatal, Mesolimbic, Mesocortical, Tuberoinfundibular)
✅ BZD = ↑ Frequency | Barbiturate = ↑ Duration (of Cl⁻ channel opening)
✅ Excitotoxicity = Excess Glutamate → Ca²⁺ overload → neuronal death
✅ Parkinson's = ↓ DA (nigrostriatal) | Schizophrenia = ↑ DA (mesolimbic)
❓ Frequently Asked Exam Questions
Q1. What is neurohumoral transmission in the central nervous system?
Neurohumoral transmission in the CNS is the process by which neurons communicate via chemical messengers (neurotransmitters) released into the synaptic cleft, which bind to receptors on the postsynaptic neuron to produce excitatory or inhibitory responses.
Q2. What is the difference between excitatory and inhibitory neurotransmitters in the CNS?
Excitatory neurotransmitters (like glutamate) depolarize the postsynaptic membrane, increasing the likelihood of an action potential (EPSP). Inhibitory neurotransmitters (like GABA and glycine) hyperpolarize the membrane, reducing the likelihood of firing (IPSP).
Q3. How do glycine and GABA act as inhibitory neurotransmitters?
Both GABA (via GABA-A receptor) and glycine (via GlyR) open Cl⁻ channels, causing Cl⁻ influx into the neuron. This hyperpolarizes the membrane (makes it more negative), making it harder to generate an action potential — thus inhibiting neuronal activity.
Q4. What is glutamate excitotoxicity and which neurological diseases does it cause?
Glutamate excitotoxicity occurs when excessive glutamate overstimulates NMDA receptors, causing massive Ca²⁺ influx into neurons, leading to mitochondrial dysfunction and cell death. It is implicated in stroke, epilepsy, ALS, Alzheimer's disease, and traumatic brain injury.
Q5. What are the four dopamine pathways and their clinical significance?
The four pathways are: (1) Nigrostriatal — motor control (Parkinson's if damaged); (2) Mesolimbic — reward/pleasure (schizophrenia positive symptoms if overactive); (3) Mesocortical — cognition (schizophrenia negative symptoms if underactive); (4) Tuberoinfundibular — prolactin inhibition (hyperprolactinemia if blocked by antipsychotics).
Q6. Which neurotransmitters are targeted by benzodiazepines and SSRIs?
Benzodiazepines target the GABA-A receptor (positive allosteric modulator → ↑ Cl⁻ channel opening frequency). SSRIs target the serotonin reuptake transporter (SERT), blocking 5-HT reuptake and increasing synaptic serotonin levels.
Q7. What is the role of serotonin in mood regulation and sleep?
Serotonin (5-HT), released from Raphe nuclei, modulates mood, sleep-wake cycles, appetite, and cognition. Low serotonin is associated with depression, anxiety, and insomnia. SSRIs increase synaptic serotonin and are first-line treatment for depression and anxiety disorders.
Q8. What is the dual role of glycine in the CNS?
Glycine has two distinct roles: (1) Inhibitory — acts on glycine receptors (GlyR, Cl⁻ channel) in the spinal cord and brainstem to inhibit motor neurons; (2) Co-agonist/Excitatory — required along with glutamate to activate NMDA receptors in the brain (binds the glycine-B site).
π¨ For Students & Educators
π‘ Meme
When your GABA is working fine vs. when it's not
π Quick Study Hacks
- Color-code your notes: Orange = Glutamate (excitatory), Blue = GABA (inhibitory), Teal = Glycine, Purple = Serotonin, Pink = Dopamine. Use the same colors every time you revise.
- Pathway cards: Make 4 index cards for dopamine pathways — write the pathway name, origin, destination, function, and disorder on each card. Quiz yourself daily for 5 days before the exam.
- Drug-receptor matching game: Write drug names on one set of sticky notes and receptor targets on another. Mix them up and match them — great for GPAT MCQ preparation.
π References
- NCBI/StatPearls article on Neurohumoral Transmission
- Merck Manual: Neurotransmission overview
- NCBI article on GABA receptors and pharmacology
- PubMed review on Dopamine pathways and CNS disorders
π£ Call to Action
Did this blog help you understand neurohumoral transmission in the CNS? π§ π
If yes, here's what to do next:
- ⭐ Bookmark this page for last-minute GPAT and university exam revision.
- π€ Share it with your classmates on WhatsApp, Telegram, or Instagram — help them score better too!
- π¬ Drop a comment below — which neurotransmitter topic do you want us to cover next? Acetylcholine? Norepinephrine? Endorphins?
- π Subscribe/Follow this blog for more GPAT-ready pharmacology notes, mnemonics, and comparison tables.
Save + share + bookmark for revision.
π Every neurotransmitter you master today is one more MCQ you'll ace tomorrow — keep going, future pharmacist!
Comments
Post a Comment